CLARIANE SE (CLARI.PA) Stock Fundamental Analysis

Europe • Euronext Paris • EPA:CLARI • FR0010386334

3.978 EUR
+0.03 (+0.86%)
Last: Feb 12, 2026, 02:35 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

3

Taking everything into account, CLARI scores 3 out of 10 in our fundamental rating. CLARI was compared to 29 industry peers in the Health Care Providers & Services industry. CLARI has a bad profitability rating. Also its financial health evaluation is rather negative. CLARI is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • CLARI had negative earnings in the past year.
  • In the past year CLARI had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: CLARI reported negative net income in multiple years.
  • Each year in the past 5 years CLARI had a positive operating cash flow.
CLARI.PA Yearly Net Income VS EBIT VS OCF VS FCFCLARI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

1.2 Ratios

  • CLARI has a worse Return On Assets (-0.43%) than 79.31% of its industry peers.
  • CLARI has a Return On Equity of -1.71%. This is in the lower half of the industry: CLARI underperforms 79.31% of its industry peers.
  • CLARI's Return On Invested Capital of 1.62% is on the low side compared to the rest of the industry. CLARI is outperformed by 82.76% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for CLARI is below the industry average of 6.49%.
Industry RankSector Rank
ROA -0.43%
ROE -1.71%
ROIC 1.62%
ROA(3y)-0.31%
ROA(5y)0%
ROE(3y)-1.27%
ROE(5y)0.01%
ROIC(3y)1.96%
ROIC(5y)2.04%
CLARI.PA Yearly ROA, ROE, ROICCLARI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 6

1.3 Margins

  • CLARI's Operating Margin of 4.79% is in line compared to the rest of the industry. CLARI outperforms 58.62% of its industry peers.
  • CLARI's Operating Margin has declined in the last couple of years.
  • CLARI has a better Gross Margin (91.90%) than 96.55% of its industry peers.
  • CLARI's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 4.79%
PM (TTM) N/A
GM 91.9%
OM growth 3Y-16.28%
OM growth 5Y-11.33%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.3%
GM growth 5Y-0.14%
CLARI.PA Yearly Profit, Operating, Gross MarginsCLARI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CLARI is destroying value.
  • Compared to 1 year ago, CLARI has more shares outstanding
  • CLARI has more shares outstanding than it did 5 years ago.
  • CLARI has a better debt/assets ratio than last year.
CLARI.PA Yearly Shares OutstandingCLARI.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
CLARI.PA Yearly Total Debt VS Total AssetsCLARI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

  • CLARI has an Altman-Z score of 0.62. This is a bad value and indicates that CLARI is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of CLARI (0.62) is worse than 75.86% of its industry peers.
  • The Debt to FCF ratio of CLARI is 13.25, which is on the high side as it means it would take CLARI, 13.25 years of fcf income to pay off all of its debts.
  • CLARI has a Debt to FCF ratio of 13.25. This is comparable to the rest of the industry: CLARI outperforms 41.38% of its industry peers.
  • A Debt/Equity ratio of 1.90 is on the high side and indicates that CLARI has dependencies on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 1.90, CLARI is doing worse than 68.97% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.9
Debt/FCF 13.25
Altman-Z 0.62
ROIC/WACC0.42
WACC3.88%
CLARI.PA Yearly LT Debt VS Equity VS FCFCLARI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.3 Liquidity

  • CLARI has a Current Ratio of 0.67. This is a bad value and indicates that CLARI is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Current ratio of CLARI (0.67) is worse than 65.52% of its industry peers.
  • A Quick Ratio of 0.65 indicates that CLARI may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.65, CLARI is in line with its industry, outperforming 48.28% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.67
Quick Ratio 0.65
CLARI.PA Yearly Current Assets VS Current LiabilitesCLARI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • CLARI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 84.92%, which is quite impressive.
  • CLARI shows a small growth in Revenue. In the last year, the Revenue has grown by 2.70%.
  • The Revenue has been growing slightly by 7.89% on average over the past years.
EPS 1Y (TTM)84.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%65.02%
Revenue 1Y (TTM)2.7%
Revenue growth 3Y8.48%
Revenue growth 5Y7.89%
Sales Q2Q%1.05%

3.2 Future

  • CLARI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 34.80% yearly.
  • CLARI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.96% yearly.
EPS Next Y80.02%
EPS Next 2Y74.89%
EPS Next 3Y53.72%
EPS Next 5Y34.8%
Revenue Next Year0.99%
Revenue Next 2Y2.46%
Revenue Next 3Y3.12%
Revenue Next 5Y2.96%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CLARI.PA Yearly Revenue VS EstimatesCLARI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B
CLARI.PA Yearly EPS VS EstimatesCLARI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.2 -0.2 0.4 0.6 0.8

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CLARI. In the last year negative earnings were reported.
  • Based on the Price/Forward Earnings ratio of 15.35, the valuation of CLARI can be described as correct.
  • The rest of the industry has a similar Price/Forward Earnings ratio as CLARI.
  • The average S&P500 Price/Forward Earnings ratio is at 28.01. CLARI is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 15.35
CLARI.PA Price Earnings VS Forward Price EarningsCLARI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CLARI indicates a somewhat cheap valuation: CLARI is cheaper than 65.52% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, CLARI is valued cheaper than 93.10% of the companies in the same industry.
Industry RankSector Rank
P/FCF 2.3
EV/EBITDA 8.48
CLARI.PA Per share dataCLARI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • CLARI's earnings are expected to grow with 53.72% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y74.89%
EPS Next 3Y53.72%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 10.64%, CLARI is a good candidate for dividend investing.
  • CLARI's Dividend Yield is rather good when compared to the industry average which is at 1.61. CLARI pays more dividend than 100.00% of the companies in the same industry.
  • CLARI's Dividend Yield is rather good when compared to the S&P500 average which is at 1.80.
Industry RankSector Rank
Dividend Yield 10.64%

5.2 History

  • The dividend of CLARI decreases each year by -7.26%.
Dividend Growth(5Y)-7.26%
Div Incr Years0
Div Non Decr Years0
CLARI.PA Yearly Dividends per shareCLARI.PA Yearly Dividends per shareYearly Dividends per share 2023 0.05 0.1 0.15 0.2

5.3 Sustainability

  • CLARI has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-110.94%
EPS Next 2Y74.89%
EPS Next 3Y53.72%
CLARI.PA Yearly Income VS Free CF VS DividendCLARI.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

More info and screens

Find the best dividend stocksShow peers with best dividend

CLARIANE SE

EPA:CLARI (2/12/2026, 2:35:31 PM)

3.978

+0.03 (+0.86%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-27
Earnings (Next)02-26
Inst Owners45.31%
Inst Owner ChangeN/A
Ins Owners5.61%
Ins Owner ChangeN/A
Market Cap1.42B
Revenue(TTM)5.31B
Net Income(TTM)-61.38M
Analysts77.14
Price Target4.51 (13.37%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 10.64%
Yearly Dividend0.19
Dividend Growth(5Y)-7.26%
DP-110.94%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.37%
PT rev (3m)-5.02%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-165.52%
EPS NY rev (3m)-154.29%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.51%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 15.35
P/S 0.27
P/FCF 2.3
P/OCF 1.61
P/B 0.4
P/tB N/A
EV/EBITDA 8.48
EPS(TTM)-0.16
EYN/A
EPS(NY)0.26
Fwd EY6.52%
FCF(TTM)1.73
FCFY43.53%
OCF(TTM)2.47
OCFY62.2%
SpS14.88
BVpS10.05
TBVpS-5.25
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.43%
ROE -1.71%
ROCE 2.21%
ROIC 1.62%
ROICexc 1.74%
ROICexgc 3.52%
OM 4.79%
PM (TTM) N/A
GM 91.9%
FCFM 11.63%
ROA(3y)-0.31%
ROA(5y)0%
ROE(3y)-1.27%
ROE(5y)0.01%
ROIC(3y)1.96%
ROIC(5y)2.04%
ROICexc(3y)2.07%
ROICexc(5y)2.22%
ROICexgc(3y)4.16%
ROICexgc(5y)4.53%
ROCE(3y)2.66%
ROCE(5y)2.78%
ROICexgc growth 3Y-9.02%
ROICexgc growth 5Y-8.45%
ROICexc growth 3Y-9.61%
ROICexc growth 5Y-8.51%
OM growth 3Y-16.28%
OM growth 5Y-11.33%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.3%
GM growth 5Y-0.14%
F-Score6
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 1.9
Debt/FCF 13.25
Debt/EBITDA 6.54
Cap/Depr 33.65%
Cap/Sales 4.99%
Interest Coverage 0.83
Cash Conversion 84.73%
Profit Quality N/A
Current Ratio 0.67
Quick Ratio 0.65
Altman-Z 0.62
F-Score6
WACC3.88%
ROIC/WACC0.42
Cap/Depr(3y)69.7%
Cap/Depr(5y)78.91%
Cap/Sales(3y)9.85%
Cap/Sales(5y)11.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)84.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%65.02%
EPS Next Y80.02%
EPS Next 2Y74.89%
EPS Next 3Y53.72%
EPS Next 5Y34.8%
Revenue 1Y (TTM)2.7%
Revenue growth 3Y8.48%
Revenue growth 5Y7.89%
Sales Q2Q%1.05%
Revenue Next Year0.99%
Revenue Next 2Y2.46%
Revenue Next 3Y3.12%
Revenue Next 5Y2.96%
EBIT growth 1Y-22.4%
EBIT growth 3Y-9.18%
EBIT growth 5Y-4.33%
EBIT Next Year283.2%
EBIT Next 3Y64.52%
EBIT Next 5Y37.45%
FCF growth 1Y267.45%
FCF growth 3Y23.92%
FCF growth 5Y6.15%
OCF growth 1Y11.15%
OCF growth 3Y2.33%
OCF growth 5Y3.29%

CLARIANE SE / CLARI.PA FAQ

What is the fundamental rating for CLARI stock?

ChartMill assigns a fundamental rating of 3 / 10 to CLARI.PA.


Can you provide the valuation status for CLARIANE SE?

ChartMill assigns a valuation rating of 5 / 10 to CLARIANE SE (CLARI.PA). This can be considered as Fairly Valued.


What is the profitability of CLARI stock?

CLARIANE SE (CLARI.PA) has a profitability rating of 3 / 10.


Can you provide the dividend sustainability for CLARI stock?

The dividend rating of CLARIANE SE (CLARI.PA) is 5 / 10 and the dividend payout ratio is -110.94%.